Familial Cold Autoinflammatory Syndrome
📧 Sign up to get email alerts when something new happens for Familial Cold Autoinflammatory Syndrome.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-09-23FDA Approved: ILARIS — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for ILARIS (canakinumab) submitted by Novartis Pharmaceuticals Corporation, resulting in an upda…
-
FDA approval · 2009-06-17FDA Approved: ILARIS — Original Application (Novartis Pharmaceuticals Corporation)
The FDA approved ILARIS (canakinumab) under the original application for treatment of cryopyrin-associated periodic syndromes, including fam…
-
FDA approval · 2008-02-27FDA Approved: ARCALYST — Original Application (Kiniksa Pharmaceuticals (UK), Ltd.)
FDA approved ARCALYST (rilonacept) from its original Biologics License Application for the treatment of cryopyrin-associated periodic syndro…